Arg-1 and GPC-3 have been extensively used to differentiate hepatocellular carcinoma cells from cholangiocarcinoma and metastatic tumor cells in the liver because of their sensitivity [19, 20]. This evidence concerns the gene GPC3 and cholangiocarcinoma.